Starpharma (see the October 2009, LRBJ) just announced the commencement of its Phase II study of VivaGel for the treatment of bacterial vaginosis (BV). It said that in July 2010 the...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)